The objective of the program committee of the Fifth International Symposium on Atherosclerosis was to bring together experts in many disciplines to broaden the scope of the attack on this disease and to foster interaction. Our hope was that such interaction would accelerate the eradication of the disease. The symposium achieved that objective and con tinued the tradition of the previous symposia in providing a forum for summaries of recent research developments in the study, treatment and prevention of atherosclerosis. The leading authorities and researchers in this field and in the related…mehr
The objective of the program committee of the Fifth International Symposium on Atherosclerosis was to bring together experts in many disciplines to broaden the scope of the attack on this disease and to foster interaction. Our hope was that such interaction would accelerate the eradication of the disease. The symposium achieved that objective and con tinued the tradition of the previous symposia in providing a forum for summaries of recent research developments in the study, treatment and prevention of atherosclerosis. The leading authorities and researchers in this field and in the related areas of interest have presented the newest information, concepts and ideas that have evolved in the past three years since the previous meeting in Tokyo. The most promising fields for future investigation are clearly identified, as are the nature of the controversies that persist in some highly important aspects of treatment of this disease. The appearance of these proceedings so soon after the meeting will greatly enhance the impact of the symposium on current research in atherosclerosis. The program committee is particularly indebted to the excellent response of the inves tigators for their willingness to participate in the symposium and for their successful efforts in bringing high quality to their presentations. Their cooperation in the expeditious delivery of manuscripts for this volume has been particularly gratifying. The efforts of Ms. Barbara Allen in preparing this volume bear special note.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Plenary Session: Cardiovascular Surgery (Co-Chairpersons: E. S. Crawford, D. C. Sabiston Jr.).- Atherosclerosis: Patterns and Rates of Progression.- Surgery for Coronary Artery Disease.- Review of 30 Years of Surgery of the Heart and the Great Vessels.- Mechanism of Progress. Page from the History of Cardiovascular Surgery.- Workshop: Coronary Bypass Surgery (Co-Chairpersons: M. E. DeBakey, J. W. Hurst).- My Current Views Regarding Coronary Bypass Surgery.- Results of Coronary Bypass: A Long-Term Perspective.- Current Views Regarding Coronary Bypass Surgery.- Comparison of Medical and Surgical Mortality in a High Risk Subset of Coronary Patients with Extreme Degrees of Exercise-Induced Ischemia.- Workshop: Epidemiology of Atherosclerotic Lesions (Co-Chairpersons: Y. Goto, J. P. Strong).- to Epidemiology of Atherosclerotic Lesions.- Epidemiology of Coronary Atherosclerosis: Postmortem vs Clinical Risk Factor Correlations. The Framingham Study.- Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study.- Atherosclerosis and Its Risk Factors Among Hawaii Japanese.- Atherosclerosis, Smoking and Other Risk Factors.- Workshop: Drug Treatment of Hyperlipidemia (Co-Chairpersons: D. Kritchevsky, R. Paoletti).- Drug Treatment of Hyperlipidemias.- Drug Treatment of Type II Hyperlipoproteinemia. Effects on Plasma Lipid and Lipoprotein Levels.- Synergism in Drug Treatment of Familial Hypercholesterolemia.- Effect of Plasma Lipoextraction and Infusion of Heterologous HDL on the Development of Experimental Atherosclerosis in Rabbits.- New Drug Treatments in Hyperlipidaemia.- Apoprotein Changes Following Treatments with Hypolipidemic Drugs.- Workshop: The Arterial Wall-I (Co-Chairpersons: M. D. Haust, K. W. Walton).- Milieu and Function of Arterial Wall-The Clues to Unique Reactivity.- Atherogenetic Factors Intrinsic to the Artery Wall.- Arterial Endothelium in the Initial Stages of Atherogenesis.- Ultrastructure of the Normal Arterial Endothelium and Intima.- Biochemical Studies on Permeability and the Interaction Between Blood Constituents and Arterial Components in Atherosclerosis.- Smooth Muscle Cells in Atherosclerosis.- Mononuclear Phagocytes in Atherosclerosis.- Altered Permeability in Atherosclerosis-Morphological Evidence.- The Elastic Element in the Arterial Wall: Biosynthesis and Degradation.- Prostacyclin Production by Vascular Smooth Muscle and Endothelial Cells.- Workshop: Lipid, Apoprotein and Lipoprotein Origin and Synthesis (Co-Chairpersons: R. J. Havel, B. Lewis).- Lipid, Apoprotein and Lipoprotein Origin and Synthesis.- Origin in Plasma of Low Density and High Density Lipoproteins.- Biological and Biochemical Aspects of ML-236B (Compactin) and Monacolin K, Specific Competitive Inhibitors of 3-hydroxy-3-methylglutaryl Coenzyme A Re-ductase.- Biosynthesis of Rat Apolipoprotein E.- Apoprotein Secretion from the Human Intestine.- Nascent VLDL and Nascent HDL from Liver.- Synthesis and Secretion of Very Low Density Lipoprotein by Cultured Rat Hepatocytes.- Workshop: Lipoprotein Structure (Co-Chairpersons: H. B. Brewer, Jr. W. Stoffel.- Topochemical Studies on Human High Density Lipoprotein.- The Associating System of Small Subunits in ApoLDL.- Lipoprotein Structure and the Mechanism of Action of Lipoprotein Lipase.- Structure of High Density Lipoproteins.- Cholesteryl Ester-Rich Very Low Density Lipoproteins: Magnetic Resonance Studies.- Plenary Session: Dietary Prevention of Coronary Heart Disease (Co-Chairpersons: R. I. Levy, G. Schettler.- Dietary Prevention of Coronary Artery Disease-A Policy Overview.- Dietary Prevention of Coronary Heart Disease.- Evaluation of the Evidence Relating National Dietary Patterns to Disease.- Diet-Lipid-Atherosclerosis Relationship: Epidemiological Evidence and Public Health Implications.- Dietary Prevention of Coronary Heart Disease: The Role of Essential Fatty Acids.- Workshop: Hyperlipidemia: Prevalence and Inheritance (Co-Chairpersons: H. A. Eder, J. Slack.- Identification o
Plenary Session: Cardiovascular Surgery (Co-Chairpersons: E. S. Crawford, D. C. Sabiston Jr.).- Atherosclerosis: Patterns and Rates of Progression.- Surgery for Coronary Artery Disease.- Review of 30 Years of Surgery of the Heart and the Great Vessels.- Mechanism of Progress. Page from the History of Cardiovascular Surgery.- Workshop: Coronary Bypass Surgery (Co-Chairpersons: M. E. DeBakey, J. W. Hurst).- My Current Views Regarding Coronary Bypass Surgery.- Results of Coronary Bypass: A Long-Term Perspective.- Current Views Regarding Coronary Bypass Surgery.- Comparison of Medical and Surgical Mortality in a High Risk Subset of Coronary Patients with Extreme Degrees of Exercise-Induced Ischemia.- Workshop: Epidemiology of Atherosclerotic Lesions (Co-Chairpersons: Y. Goto, J. P. Strong).- to Epidemiology of Atherosclerotic Lesions.- Epidemiology of Coronary Atherosclerosis: Postmortem vs Clinical Risk Factor Correlations. The Framingham Study.- Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study.- Atherosclerosis and Its Risk Factors Among Hawaii Japanese.- Atherosclerosis, Smoking and Other Risk Factors.- Workshop: Drug Treatment of Hyperlipidemia (Co-Chairpersons: D. Kritchevsky, R. Paoletti).- Drug Treatment of Hyperlipidemias.- Drug Treatment of Type II Hyperlipoproteinemia. Effects on Plasma Lipid and Lipoprotein Levels.- Synergism in Drug Treatment of Familial Hypercholesterolemia.- Effect of Plasma Lipoextraction and Infusion of Heterologous HDL on the Development of Experimental Atherosclerosis in Rabbits.- New Drug Treatments in Hyperlipidaemia.- Apoprotein Changes Following Treatments with Hypolipidemic Drugs.- Workshop: The Arterial Wall-I (Co-Chairpersons: M. D. Haust, K. W. Walton).- Milieu and Function of Arterial Wall-The Clues to Unique Reactivity.- Atherogenetic Factors Intrinsic to the Artery Wall.- Arterial Endothelium in the Initial Stages of Atherogenesis.- Ultrastructure of the Normal Arterial Endothelium and Intima.- Biochemical Studies on Permeability and the Interaction Between Blood Constituents and Arterial Components in Atherosclerosis.- Smooth Muscle Cells in Atherosclerosis.- Mononuclear Phagocytes in Atherosclerosis.- Altered Permeability in Atherosclerosis-Morphological Evidence.- The Elastic Element in the Arterial Wall: Biosynthesis and Degradation.- Prostacyclin Production by Vascular Smooth Muscle and Endothelial Cells.- Workshop: Lipid, Apoprotein and Lipoprotein Origin and Synthesis (Co-Chairpersons: R. J. Havel, B. Lewis).- Lipid, Apoprotein and Lipoprotein Origin and Synthesis.- Origin in Plasma of Low Density and High Density Lipoproteins.- Biological and Biochemical Aspects of ML-236B (Compactin) and Monacolin K, Specific Competitive Inhibitors of 3-hydroxy-3-methylglutaryl Coenzyme A Re-ductase.- Biosynthesis of Rat Apolipoprotein E.- Apoprotein Secretion from the Human Intestine.- Nascent VLDL and Nascent HDL from Liver.- Synthesis and Secretion of Very Low Density Lipoprotein by Cultured Rat Hepatocytes.- Workshop: Lipoprotein Structure (Co-Chairpersons: H. B. Brewer, Jr. W. Stoffel.- Topochemical Studies on Human High Density Lipoprotein.- The Associating System of Small Subunits in ApoLDL.- Lipoprotein Structure and the Mechanism of Action of Lipoprotein Lipase.- Structure of High Density Lipoproteins.- Cholesteryl Ester-Rich Very Low Density Lipoproteins: Magnetic Resonance Studies.- Plenary Session: Dietary Prevention of Coronary Heart Disease (Co-Chairpersons: R. I. Levy, G. Schettler.- Dietary Prevention of Coronary Artery Disease-A Policy Overview.- Dietary Prevention of Coronary Heart Disease.- Evaluation of the Evidence Relating National Dietary Patterns to Disease.- Diet-Lipid-Atherosclerosis Relationship: Epidemiological Evidence and Public Health Implications.- Dietary Prevention of Coronary Heart Disease: The Role of Essential Fatty Acids.- Workshop: Hyperlipidemia: Prevalence and Inheritance (Co-Chairpersons: H. A. Eder, J. Slack.- Identification o
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826